Gadolinium
Overview
Gadolinium possesses unusual metallurgic properties, with high neutron absorption capabilities and remarkable magnetic characteristics. It's widely used in medical imaging as MRI contrast agents, improving the clarity of internal body structures. Gadolinium's unique magnetic properties also make it valuable for magnetic refrigeration technology, offering an energy-efficient alternative to conventional cooling systems.
Appearance
Silvery-white, malleable and ductile
Electron Configuration
[Xe] 4f⁷5d¹6s²
Density
7.90 g/cm³
Melting Point
1313°C
Discovery
Discovery Timeline
Primary Uses
- MRI contrast agents
- Nuclear reactor shielding
- Computer memory
- Magnetic refrigeration
Application Sectors
Economic Value
Current Price
$55 per kg
Price Trend
Supply Risk
Primary Producers
Investing in Gadolinium
- Gadolinium oxide (99.9%) trades at US $55-65 /kg FOB China (≈ US $0.06 /g) as of May 2025.
- European spot prices reach US $75-85 /kg due to medical certification requirements.
- Asian Metal's index shows steady growth driven by MRI contrast agent demand.
- Small-lot investors face 30-40% premiums above bulk prices.
- Metal prices carry 35-40% premium over oxide due to processing requirements.
How to Get Exposure
Route | Why It Appeals | Watch-outs |
---|---|---|
Physical metal/oxide | Direct exposure to medical imaging growth | Storage, handling requirements |
Mining stocks | Operational leverage potential | Limited pure-play options |
ETFs | Broader rare earth exposure | Minimal Gd-specific exposure |
Market Outlook
- Medical imaging driving steady demand growth.
- Magnetic refrigeration applications showing promise.
- Nuclear applications providing baseline demand.
- Supply remains concentrated but less critical than other REEs.
FAQs
Why invest in Gadolinium?
It offers exposure to the growing medical imaging and magnetic refrigeration markets.
How volatile is the market?
Prices are relatively stable with steady growth driven by medical demand.
Disclaimer: Market data is indicative and updates frequently; nothing here constitutes financial advice.